Daily Archives: October 6, 2017

I read with great interest the report of Shabanzadeh et al.1 In a cohort study, they found that around 10% of participants had screen-detected gallstone disease, gallstones, and cholecystectomy. Subjects with gallstone disease had a significantly high… Continue reading →

Outcomes of liver transplantation for hepatocellular carcinoma (HCC) are determined by cancer-related and non-related events. Treatments for hepatitis C virus (HCV) infection have reduced non-cancer events among patients receiving liver transplants, so… Continue reading →

We have explored associations for screen-detected gallstone disease and cancer in a Danish general population cohort and identified associations for gallstone disease and incident gastrointestinal cancer, especially for right-side colon cancer.1 Based … Continue reading →

Viggars et al offer 3 reasons why they believe the results of our systematic review with meta-analysis assessing probiotic efficacy for prevention of Clostridium difficile infection should be downgraded from high to low or possibly very low quality of… Continue reading →

Vedolizumab, a monoclonal immunoglobulin (Ig)G4 antibody, has a favorable safety profile in nonpregnant and nonlactating patients.1 The data on the safety of vedolizumab in reproduction is limited,2,3 with currently none available in lactating mothers. Continue reading →